Synthetic IL-15 could moderately diminish liver injury in concanavalin A or Fas ligand-induced hepatitis [25], [26], whereas DC-derived IL-15 enhanced endotoxin shock injury through the liver [27]. The gene discussed is IL15; the disease is Hepatitis.